Komori
Onex (5987) · InitiativeRecorded ¥31 million in R&D expenses

Technology development to address the increasingly diverse and sophisticated needs of business partners

First written in FY2016. 28 of 30 entries say "Restated". Latest entry: FY2026.

30entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20262016: 22017: 420172018: 420182019: 420192020: 420202021: 320212022: 320222023: 320232024: 120242025: 020252026: 22026
Same theme, other companies
Strengthening New Product and Technology Development Capabilities Through R&D and Basic ResearchA theme 216 companies write about · 0 as a headwind · 228 as a tailwind

11 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Recorded ¥31 million in R&D expensesAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥31 million. The main research areas were as follows.」

    We continued to research new heat treatment technologies, centered on the Technology Research Institute, and to develop proposal-based technologies addressing customer needs, recording total R&D expenses of ¥31 million.
  2. FY2026-H1RestatedAnnual report

    「The Group’s total R&D expenditure during the interim consolidated accounting period was ¥17 million. There were no material changes in the status of the Group’s R&D activities during the interim consolidated accounting period.」

    States that there were no material changes in R&D activities and that R&D expenses for the interim consolidated accounting period were ¥17 million.
  3. FY2024-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥11 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative second quarter were ¥11 million.
  4. FY2024-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥5 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the quarter were ¥5 million.
  5. FY2023-Q3RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative third quarter was ¥16 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative third quarter were ¥16 million.
  6. FY2023-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥11 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative second quarter were ¥11 million.
  7. FY2023-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥5 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that R&D expenses were ¥5 million and that there were no material changes in the status of R&D activities.
  8. FY2022-Q3RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative third quarter was ¥17 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    States that R&D expenses were ¥17 million and that there were no material changes in the status of R&D activities.
  9. FY2022-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥11 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative second quarter were ¥11 million.
  10. FY2022-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥5 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the quarter were ¥5 million.
  11. FY2021RestatedAnnual report

    「Our Group’s metal heat treatment processing business continues to research new heat treatment technologies, centered on the Technology Research Institute. At the same time, our basic approach is to develop technologies that address and propose solutions to our customers’ increasingly diverse and sophisticated needs.」

    We continue to research new heat treatment technologies, centered on the Technology Research Institute, and to develop proposal-based technologies addressing customer needs. Total R&D expenses were ¥25 million.
  12. FY2021-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥13 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative second quarter were ¥13 million.
  13. FY2021-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥5 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative first quarter were ¥5 million.
  14. FY2020RestatedAnnual report

    「Our Group’s metal heat treatment processing business continues to research new heat treatment technologies, centered on the Technology Research Institute. At the same time, our basic approach is to develop technologies that address and propose solutions to our customers’ increasingly diverse and sophisticated needs.」

    We continue to research new heat treatment technologies, centered on the Technology Research Institute, and to develop proposal-based technologies addressing customer needs. Total R&D expenses were ¥26 million.
  15. FY2020-Q3RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative third quarter was ¥22 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative third quarter were ¥22 million.
  16. FY2020-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥13 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that there were no material changes in the status of R&D activities and that R&D expenses for the cumulative second quarter were ¥13 million.
  17. FY2020-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥7 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative first quarter were ¥7 million.
  18. FY2019RestatedAnnual report

    「Our Group’s metal heat treatment processing business continues to research new heat treatment technologies, centered on the Technology Research Institute. At the same time, our basic approach is to develop technologies that address and propose solutions to our customers’ increasingly diverse and sophisticated needs.」

    We continue to research new heat treatment technologies, centered on the Technology Research Institute, and to develop proposal-based technologies addressing customer needs. Total R&D expenses were ¥36 million.
  19. FY2019-Q3RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative third quarter was ¥27 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative third quarter were ¥27 million.
  20. FY2019-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥18 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that R&D expenses were ¥18 million and that there were no material changes in the status of R&D activities.
  21. FY2019-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥8 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that R&D expenses were ¥8 million and that there were no material changes in the status of R&D activities.
  22. FY2018RestatedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥36 million. The main research areas were as follows.」

    We continue to research new heat treatment technologies, centered on the Technology Research Institute, and to develop proposal-based technologies addressing customer needs. Total R&D expenses were ¥36 million.
  23. FY2018-Q3RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative third quarter was ¥25 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative third quarter were ¥25 million.
  24. FY2018-Q2RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative second quarter was ¥17 million. There were no material changes in the status of the Group’s R&D activities during the cumulative second quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the cumulative second quarter were ¥17 million.
  25. FY2018-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥8 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that R&D expenses were ¥8 million and that there were no material changes in the status of R&D activities.
  26. FY2017RestatedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥34 million. The main research areas were as follows.」

    We continue to research new heat treatment technologies, centered on the Technology Research Institute, and to develop proposal-based technologies addressing our customers’ increasingly diverse and sophisticated needs. Total R&D expenses were ¥34 million, with no material changes in the status of these activities.
  27. FY2017-Q3RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative third quarter was ¥27 million. There were no material changes in the status of the Group’s R&D activities during the cumulative third quarter.」

    States that R&D expenses were ¥27 million and that there were no material changes in the status of R&D activities.
  28. FY2017-Q2RestatedAnnual report

    「The Group's total research and development expenditure during the six-month period of the current consolidated fiscal year was ¥19 million. There were no material changes in the status of the Group's research and development activities during the six-month period of the current consolidated fiscal year.」

    States that R&D expenses were ¥19 million and that there were no material changes in the status of R&D activities.
  29. FY2017-Q1RestatedAnnual report

    「The Group’s total R&D expenditure during the cumulative first quarter was ¥8 million. There were no material changes in the status of the Group’s R&D activities during the cumulative first quarter.」

    States that there were no material changes in R&D activities and that R&D expenses for the quarter were ¥8 million.
  30. FY2016First statedAnnual report

    「We continue to conduct research into new heat treatment technologies, centered on the Technology Research Institute. At the same time, our basic approach is to develop technologies that address and propose solutions to our customers’ increasingly diverse and sophisticated needs.」

    R&D is centered on research at the Technology Research Institute and proposal-based technology development addressing customer needs.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Onex yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Technology development to address the increasingly diverse and sophisticated needs of business partners | ONEX Corporation (5987) | Komori